FcγRIIIa expression on monocytes in rheumatoid arthritis: Role in immune-complex stimulated TNF production and non-response to methotrexate therapy

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Cooper, Dawn L ^a   Martin, Stephen G ^a   Robinson, James I ^a   Mackie, Sarah L ^a   Charles, Christopher J ^a   Nam, Jackie ^a   Isaacs, John D ^b   Emery, Paul ^a   Morgan, Ann W ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD14 ANTIGEN; CD16 ANTIGEN; CYTOKINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FC GAMMA RECEPTOR IIIA; IMMUNOGLOBULIN; LIPOPOLYSACCHARIDE; METHOTREXATE; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; FC RECEPTOR; FCGR3A PROTEIN, HUMAN; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE INCREASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOGLOBULIN AGGREGATE; IN VITRO STUDY; MALE; MONOCYTE; RHEUMATOID ARTHRITIS; BIOSYNTHESIS; CASE CONTROL STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MONOCYTES; RECEPTORS, IGG; RETROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84855303727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028918     Document Type: Article

References (50)

1. Edwards JCW, (1998) Is rheumatoid factor relevant? In: Bird HA, Snaith M, editors. Questions and uncertainties in rheumatoid arthritis.
2. Mewar D, Wilson AG, (2006) Autoantibodies in rheumatoid arthritis: a review. Biomed Pharmacother 60: 648-655.
3. Nimmerjahn F, Ravetch JV, (2007) Fc-receptors as regulators of immunity. Adv Immunol 96: 179-204.
4. Nimmerjahn F, Ravetch JV, (2008) Fc gamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47.
5. Dijstelbloem HM, van de Winkel JGJ, Kallenberg CGM, (2001) Inflammation in autoimmunity: receptors for IgG revisited. Trends Immunol 22: 510-516.
6. Blom AB, Van Lent PLEM, Holthuysen AEM, Jacobs C, van den Berg WB, (2003) Skewed balance in basal expression and regulation of activating v inhibitory Fcg receptors in macrophages of collagen induced arthritis sensitive mice. Ann Rheum Dis 62: 465-471.
7. Kleinau S, (2003) The impact of Fc receptors on the development of autoimmune diseases. Curr Pharm Des 9: 1861-1870.
8. Ravetch JV, Bolland S, (2001) IgG Fc Receptors. Annu Rev Immunol 19: 275-290.
9. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FMA, et al. (2002) Arthritis critically dependent on innate immune system players. Immunity 16: 157-168.
10. Diaz dS, Andren M, Martinsson P, Verbeek JS, Kleinau S, (2002) Expression of FcgammaRIII is required for development of collagen-induced arthritis. Eur J Immunol 32: 2915-2922.
11. Blom AB, van Lent PL, van Vuuren H, Holthuysen AE, Jacobs C, et al. (2000) Fc gamma R expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA). Arthritis Res 2: 489-503.
12. Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, (2006) Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 7: 284-292.
13. Wipke BT, Wang Z, Nagengast W, Reichert DE, Allen PM, (2004) Staging the initiation of autoantibody-induced arthritis: A critical role for immune complexes. J Immunol 172: 7694-7702.
14. Robinson JI, Barrett JH, Taylor JC, consortium YEAR, Naven M, et al. (2010) Dissection of the FCGR3A association with RA: increased association in men and with autoantibody positive disease. Ann Rheum Dis 69: 1054-1057.
15. Burmester GR, Stuhlmüller B, Keyszer G, Kinne RW, (1997) Mononuclear phagocytes and rheumatoid synovitis: mastermind or workhorse in arthritis? Arthritis Rheum 40: 5-18.
16. Wikaningrum R, Highton J, Parker A, Coleman M, Hessian PA, et al. (1998) Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient. Arthritis Rheum 41: 1783-1797.
17. Gerber J, Mosser D, (2001) Stimulatory and inhibitory signals originating from the macrophage Fc gamma receptor. Microbes Infect 3: 131-139.
18. Shahrara S, Pickens SR, Dorfleutner A, Pope RM, (2009) IL-17 induces monocyte migration in rheumatoid arthritis. J Immunol 182: 3884-3891.
19. Evans HG, Gullick NJ, Kelly S, Pitzalis C, Lord GM, et al. (2009) In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. PNAS 106: 6232-6237.
20. Marsh CB, Pomerantz RP, Parker JM, Winnard AV, Mazzaferri EL Jr, et al. (1999) Regulation of monocyte survival in vitro by deposited IgG: role of macrophage colony-stimulating factor. J Immunol 162: 6217-6225.
21. Abrahams VM, Cambridge G, Lydyard PM, Edwards JCW, (2000) Induction of tumor necrosis factor a production by adhered human monocytes. A key role for Fcg receptor type IIIA in rheumatoid arthritis. Arthritis Rheum 43: 608-616.
22. Feldmann M, Maini RN, (2001) Anti-TNFa therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19: 163-196.
23. Mertens M, Singh JA, (2009) Anakinra for rheumatoid arthritis: A systematic review. J Rheumatol 36: 1118-1125.
24. Danks L, Sabokbar A, Gundle R, Athanasou NA, (2002) Synovial macrophage-osteoclast differentiation in inflammatory arthritis. Ann Rheum Dis 61: 916-921.
25. Ziegler-Heitbrock L, (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81: 584-592.
26. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, et al. (2010) Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors. Immunity 33: 375-386 doi:10.1016/j.immuni.2010.08.012.
27. Ziegler-Heitbrock HW, (2000) Definition of human blood monocytes. J Leukoc Biol 67: 603-606.
28. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N, (1995) CD14lowCD16high: a cytokine producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 25: 3418-3424.
29. Fingerle-Rowson G, Angstwurm M, Andreesen R, Ziegler-Heitbrock HWL, (1998) Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy. Clin Exp Immunol 112: 501-506.
30. Scherberich JE, Nockher WA, (1999) CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy. Clin Chem Lab Med 37: 209-213.
31. Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, et al. (2002) CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 46: 2578-2586.
32. Cairns AP, Crockard AD, Bell AL, (2002) The CD14+ CD16+ monocyte subset in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol Int 21: 189-192.
33. Mobley JL, Leininger M, Madore S, Baginski TJ, Renkiewicz R, (2007) Genetic evidence of a functional monocyte dichotomy. Inflammation 30: 189-197.
34. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, et al. (2004) Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 50: 1457-1467.
35. Wijngaarden S, van Roon JAG, van de Winkel JGJ, Bijlsma JWJ, Lafeber FPJG, (2005) Down-regulation of activating Fcg receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment. Rheumatology 44: 729-734.
36. Laurent L, Clavel C, Lemaire O, Anquetil F, Cornillet M, et al. (2011) Fcg receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Ann Rheum Dis 70: 1052-1059.
37. Hepburn AL, Mason JC, Davies KA, (2004) Expression of Fcg and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology 43: 547-554.
38. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, et al. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 168: 3536-3542.
39. Van Lent PLEM, Holthuysen AEM, van den Bersselaar L, van Rooijen N, van de Putte LBA, et al. (1995) Role of macrophage-like synovial lining cells in localization and expression of experimental arthritis. Scand J Rheumatol 24: 83-89.
40. Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, et al. (2008) Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 58: 678-688.
41. Mullazehi M, Mathsson L, Lampa J, Ronnelid J, (2006) Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor a, interleukin-1b, and interleukin-8 from peripheral blood monocytes via fcg receptor IIA: A potential pathophysiologic mechanism for humoralanti-type II collagen immunity in arthritis. Arthritis Rheum 54: 1759-1771.
42. Mathsson L, Lampa J, Mullazehi M, Ronnelid J, (2006) Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells. Arthritis Res Ther 8: R64.
43. Arnett FC, Edworth SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American-Rheumatism-Association 1987 revised criteria for the classification of rheumatoid-arthritis. Arthritis Rheum 31: 315-324.
44. Morgan AW, Keyte VH, Babbage SJ, Robinson JI, Ponchel F, et al. (2003) FcgRIIIA-158V and rheumatoid arthritis. A confirmation study. Rheumatology (Oxford) 42: 528-533.
45. Morgan AW, Griffiths B, Ponchel F, Montague BMN, Ali M, et al. (2000) Fcg receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum 43: 2328-2334.
46. Hamano Y, Arase H, Saisho H, Saito T, (2000) Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J Immunol 164: 6113-6119.
47. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Théry C, et al. (1999) Fcg receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalisation. J Exp Med 189: 371-380.
48. Signorino E, Brusa D, Granata R, Malavasi F, Ferrone S, et al. (2007) Contribution of dendritic cells FcγRI and FcγRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies. Cancer Biol Ther 6: 1932-1937.
49. Herrada AA, Contreras FJ, Tobar JA, Pacheco R, Kalergis AM, (2007) Immune complex-induced enhancement of bacterial antigen presentation requires FcγReceptor III expression on dendritic cells. PNAS 104: 13402-13407.
50. Ancuta P, Moses A, Gabuzda D, (2004) Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 209: 11-20.